Anebulo Pharmaceuticals, Inc.
ANEB- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001815974
No open-market purchases or sales by Anebulo Pharmaceuticals, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Anebulo Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Anebulo Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Cundy Kenneth C | Chief Scientific Officer | – | Apr 7, 2025 | 0 |
| Aryeh Jason | Director | – | Apr 7, 2025 | 0 |
| Shah Bimal R. | Director | – | Apr 7, 2025 | 0 |
| Cunningham, Richard Anthony | Chief Executive Officer | – | Apr 7, 2025 | 0 |
| Lawler Joseph F. | Director, 10% Owner | – | Apr 7, 2025 | 0 |
| English Aron R. | Director, 10% Owner | 15,467,300Indirect | Apr 7, 2025 | 0 |
| Lin Kenneth | Director | – | Apr 7, 2025 | 0 |
| Kupchyk Areta | Director | – | Apr 7, 2025 | 0 |
| Calloway Nathaniel | Director | – | Apr 7, 2025 | 0 |
| 22NW Fund, LP | 10% Owner | 15,467,300Indirect | Dec 26, 2024 | 0 |
| 22NW, LP | 10% Owner | 5,366,290Indirect | Dec 20, 2023 | 0 |
| Allen Simon | Chief Executive Officer | – | Dec 13, 2022 | 0 |
| Parschauer Karah Herdman | Director | – | Oct 3, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 26, 2024 (view filing)4:15 PM ET | Dec 23 | 3 days | English Aron R. and 1 otherDirector, 10% Owner | PPurchase | +10.1M | $0.99 | +$10.0M | +188.2%15.5M after | |
| Dec 21, 2021 (view filing)8:39 PM ET | Dec 17 | 4 days | English Aron R. and 1 otherDirector, 10% Owner, Other: See Explanation of Responses | PPurchaseCommon Stock, par value $0.001 per share | +400 | $6.59 | +$2.63K | 0.0%3.36M after | |
| Dec 16, 2021 (view filing)11:37 AM ET | Dec 14 | 2 days | English Aron R. and 1 otherDirector, 10% Owner, Other: See Explanation of Responses | PPurchaseCommon Stock, par value $0.001 per share | +412 | $5.90 | +$2.43K | 0.0%3.36M after | |
| Dec 3, 2021 (view filing)7:58 PM ET | Dec 3 | Same day | English Aron R. and 1 otherDirector, 10% Owner, Other: See Explanation of Responses | PPurchaseCommon Stock, par value $0.001 per share | +4.50K | $5.93 | +$26.7K | +0.1%3.36M after | |
| Dec 3, 2021 (view filing)11:16 AM ET | Dec 2 | 1 day | English Aron R. and 1 otherDirector, 10% Owner, Other: See Explanation Response | PPurchaseCommon Stock, par value $0.001 per share | +13.8K | $5.30 | +$73.3K | +0.4%3.36M after |